Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126492) titled 'A Safety Study and PET/CT Imaging of 68Ga-ZS2004 Injection in Patients with Breast Cancer and Prostate Cancer' on June 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chinese People's Liberation Army (PLA) General Hospital
Condition:
Breast Cancer, Prostate Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-10
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324300
Published by HT Digital Content Services with permission from Health Daily Dig...